Denali Therapeutics (DNLI) Depreciation and Depletion (2017 - 2018)
Denali Therapeutics (DNLI) reported Depreciation and Depletion of $2.3 million for Q3 2018, up 199.1% year-over-year from $778000.0 in Q3 2017, and up 25.44% quarter-over-quarter from $1.9 million in Q2 2018.
Denali Therapeutics (DNLI) Depreciation and Depletion (2017 - 2018) Analysis & Trends
Denali Therapeutics (DNLI) has 2 years of Depreciation and Depletion data on file, last reported at $2.3 million in Q3 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1,395.22 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1,330.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Denali Therapeutics | 4.35 Bn | 4.35 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | 2.33 Mn |
| Sep 30, 2018 | 2.33 Mn |
| Jun 30, 2018 | 1.86 Mn |
| Jun 30, 2018 | 1.86 Mn |
| Mar 31, 2018 | 854,000.00 |
| Mar 31, 2018 | 854,000.00 |
| Sep 30, 2017 | 778,000.00 |
| Sep 30, 2017 | 778,000.00 |
| Jun 30, 2017 | 766,000.00 |
| Jun 30, 2017 | 766,000.00 |
| Mar 31, 2017 | 731,000.00 |
| Mar 31, 2017 | 731,000.00 |